425: CoreWeave Rejects Higher Bid for Core Scientific

CoreWeave CEO Michael Intrator confirmed the company will not increase its $9 billion acquisition offer for Core Scientific despite investor objections.

Summary

• CoreWeave CEO Michael Intrator stated the company will not revise its $9 billion bid for Core Scientific Inc.
• Core Scientific investor Two Seas Capital LP is voting against the deal, citing inadequate valuation, deficient structure, and a flawed process.
• The merger is scheduled for a shareholder vote on October 30.
• CoreWeave's original offer in July valued Core Scientific at $20.40 per share.
• Core Scientific shares dropped 8.4% to $16.41 following Intrator's remarks on October 7, 2025.
• CoreWeave aims to acquire approximately one gigawatt of data center capacity from Core Scientific, an existing partner.
• Intrator characterized Core Scientific's contribution as a "small and shrinking part" of CoreWeave's portfolio.
• The deal spread has remained negative for months, with CoreWeave's all-stock offer value consistently below Core Scientific's trading price, indicating market skepticism about the deal's value or completion.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to CoreWeave's firm stance against increasing its bid, leading to a significant drop in Core Scientific's share price and public opposition from a major investor. While CoreWeave is confident in its valuation, the market's reaction and the negative deal spread suggest a lack of enthusiasm for the current terms.

Positives

• CoreWeave maintains a strong commitment to the $9 billion acquisition of Core Scientific, indicating strategic importance for its AI-focused cloud computing operations.
• The acquisition would provide CoreWeave with approximately one gigawatt of data center capacity, supporting its expansion in high-performance computing.
• CoreWeave and Core Scientific are already partners, suggesting a foundation for a potentially smoother integration process if the deal proceeds.

Negatives

• CoreWeave's refusal to increase its $9 billion bid has been met with public opposition from a significant Core Scientific investor, Two Seas Capital LP, which deems the offer inadequate.
• Core Scientific's shares fell 8.4% to $16.41 after CoreWeave's CEO stated the bid would not change, indicating a negative market reaction.
• The deal spread has been negative for months, with CoreWeave's all-stock offer value consistently below Core Scientific's trading price, suggesting market skepticism about the deal's value or completion.
• The CEO's comment that Core Scientific's contribution is a "small and shrinking part of our portfolio" could be perceived negatively by Core Scientific shareholders and impact deal support.

Risks

• Uncertainty regarding the completion of the proposed transaction on anticipated terms, or at all, and the timing of completion, including obtaining Core Scientific stockholder approval.
• Fluctuations in the market price of CoreWeave common stock could impact the value of consideration Core Scientific stockholders would receive.
• The possibility that any of the anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period.
• Challenges in successfully integrating CoreWeave and Core Scientific businesses and achieving anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.
• Disruptions from the proposed transaction harming CoreWeave's or Core Scientific's business, including current plans and operations, and diverting management's time and attention.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and CoreWeave's and Core Scientific's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions.
• Acts of terrorism or outbreak of war, hostilities, civil unrest, attacks, and other political or security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events.
• The impacts of pandemics or other public health crises, including the effects of government responses on people and economies.
• Global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites.

Future Outlook

CoreWeave's CEO stated that the company will not readdress its $9 billion bid for Core Scientific, emphasizing that it fairly represents the value. Regardless of the shareholder vote outcome on October 30, CoreWeave expects to maintain a strong relationship with Core Scientific. The company anticipates the acquisition will be beneficial for both entities moving forward.

Management Comments

• "Really under no circumstances will we readdress the bid that we put out. That's the number. We think it fairly represents the value for them." Michael Intrator, CoreWeave CEO.
• "We think it will be great for the two companies to move forward together." Michael Intrator, CoreWeave CEO.
• "This [Core Scientific's contribution] as a small and shrinking part of our portfolio." Michael Intrator, CoreWeave CEO.
• "Regardless of the outcome of this acquisition, we will continue to have a great relationship with them." Michael Intrator, CoreWeave CEO.

Industry Context

The proposed acquisition highlights the increasing demand for data center capacity, particularly for artificial intelligence (AI) focused cloud computing, as CoreWeave seeks to expand its infrastructure. The negative deal spread and investor opposition reflect broader market scrutiny on M&A valuations in a dynamic tech environment, where the perceived value of assets like data centers for AI can be contentious. The conversion of crypto mining facilities to high-performance computing sites is a notable trend in the data center industry, as companies repurpose infrastructure to meet evolving technological demands.

Comparison to Industry Standards

• The negative deal spread, where the offer value is below the target's trading price, is rare for a large acquisition, suggesting market skepticism compared to typical M&A transactions where the offer usually includes a premium.
• The acquisition of 1 gigawatt of data center capacity is substantial, positioning CoreWeave to significantly scale its AI cloud computing operations, comparable to major cloud providers like Amazon Web Services or Microsoft Azure expanding their infrastructure for AI workloads.
• The conversion of crypto mining facilities to high-performance computing (HPC) sites by Core Scientific aligns with an industry trend where companies are repurposing energy-intensive infrastructure to meet the growing demand for AI compute, a strategy also pursued by other data center operators seeking to optimize asset utilization.

Legal Proceedings

• Potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific or their respective directors and officers.

Stakeholder Impact

• Shareholders (Core Scientific): Face uncertainty regarding the deal's completion and the value of their shares, especially with the current offer being below market price and no increase expected. Potential for dilution if the deal goes through as an all-stock offer.
• Shareholders (CoreWeave): Potential for dilution due to the issuance of new shares for the acquisition.
• Management (Both companies): Time and attention will be diverted to transaction-related issues, potentially impacting operational focus.
• Employees (Both companies): Potential for business disruptions and integration challenges post-merger, which could affect roles and responsibilities.
• Customers/Suppliers (Both companies): Potential for adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Core Scientific shareholders will vote on the merger on October 30.
• CoreWeave and Core Scientific will continue to file relevant materials with the SEC regarding the proposed transaction.

Key Dates

Recommendation

The current situation presents significant uncertainty for Core Scientific shareholders. CoreWeave's firm refusal to increase its $9 billion bid, coupled with public opposition from a major investor and a negative deal spread, suggests the acquisition may not proceed as planned or on favorable terms. The 8.4% drop in Core Scientific's stock price reflects this market skepticism. Investors should hold their position to await the outcome of the October 30 shareholder vote and monitor any further developments. A 'sell' at this point could lock in losses if the deal somehow improves or another bidder emerges, while a 'buy' is too risky given the current opposition and valuation concerns.

Keywords

CoreWeave, Core Scientific, Acquisition, Merger, AI, Cloud Computing, Data Center, Shareholder Vote, M&A, SEC Filing, Michael Intrator, Two Seas Capital